BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 25, 2021
View Archived Issues
"Invisible" T cells bioengineered from human iPSCs
Read More
New purine-nucleoside phosphorylase inhibitors identified at IOCB
Read More
Jiangsu Hansoh Pharmaceutical, Shanghai Hansoh Biomedical patent 5-HT2A antagonists/DRD3 agonists
Read More
Ribon Therapeutics discovers TIPARP inhibitors
Read More
New N-acetyl-beta-D-glucosaminidase inhibitors described by Biogen
Read More
Bristol Myers Squibb identifies new TLR7/8/9 antagonists
Read More
Promising data from PDAC arm of the ongoing CANFOUR study of nadunolimab plus chemotherapy
Read More
Regulus reports updated results from phase Ib study of RGLS-4326 in ADPKD
Read More
Long-term reduced dose regimen with sargramostim shows improved safety in patients with PD
Read More
New plasma proteomic biomarkers of OCAD among patients with diabetes
Read More
HMGCR variant linked to diabetes in premature triple-vessel disease patients
Read More
FXIa inhibitor BMS-986177 well tolerated in patients with renal impairment
Read More
Pfizer evaluates 20vPnC coadministered with booster dose of COVID-19 vaccine
Read More
Pilot study evaluates NT-I7 in progressive multifocal leukoencephalopathy
Read More
Phase IIb study of aldafermin in F2/F3 NASH does not meet primary endpoint
Read More
SZN-1326 induces mucosal healing in an acute injury model of IBD
Read More
FDA approves IND for phase I trial of Scopus' CpG-STAT3siRNA
Read More
Cynata begins MEND trial of Cymerus mesenchymal stem cells in respiratory failure
Read More
Initial data reported from phase Ib study of Betalutin with rituximab in second-line FL
Read More
Nasally administered foralumab studied in secondary progressive multiple sclerosis
Read More
Kiromic submits IND for CAR T-cell therapy KB-ISM
Read More